ANRI — Full Portfolio
14 tracked investments · listed companies and verified rows first
Chompy builds a food delivery service and offers a free service (beta) that lets restaurants and food retail brands create their own official app and website.
FoodTechMarketplacesSaaSTokyo, JP
大見 周平(代表取締役)Tatsuya Yagi(Founder)in八木 達也(取締役CTO)
Co-investorsCoral CapitalDelight VenturesDCM VenturesGreenoaksW Inc.
Cosomil develops single-molecule enzyme activity measurement technology for early disease diagnosis and drug development support in healthcare.
BiotechDeep TechDigital HealthHealthtechMedical DevicesTokyo, JP
鏡味 優(Representative Director (CEO))坂本 眞伍(Chief Technology Officer)
Co-investorsCoral CapitalDelight Ventures
Jamm is a Tokyo-based fintech company building a payment product for Japan's market, focused on secure authentication, low fees by removing intermediaries, and payments made without lending to users.
FintechTokyo, JP
橋爪 捷(代表取締役 (CEO))
Co-investorsDG Daiwa VenturesXTech VenturesCoreline Ventures
Morus Inc. is a Japanese company established in April 2021 and led by CEO Ryo Sato.
AgTechBiotechFoodTechSector AgnosticWellness & Fitness
Kunihiro Shiomi(Co-founder (Professor, Shinshu University))Ryo Sato(CEO)in
Co-investorsDG Daiwa VenturesGlobisHachijuni CapitalMizuho CapitalSamurai IncubateSMBC Venture Capital+1 more
Myrodia Therapeutics is a Japanese biopharmaceutical company developing drug candidates based on its "sensory drug discovery" concept, which uses sensory stimuli to induce artificial hibernation and protective physiological states.
BiotechDeep TechHealthtech
小早川 高(CSO / Founder)小早川 令子(Founder)神谷 勇輝(CEO / 代表取締役)水野 敦之(CFO)小林 実(COO)
Co-investorsRemiges Ventures, Inc.RDiscovery
SPeak provides a career platform for young international talent seeking employment in Japan, and an HR tech solution for companies recruiting global workers.
B2B MarketplacesEdTechHR TechTokyo, JP
Hiromi Karahashi(CEO)in
Co-investorsEast VenturesGlobal BrainKDDI Open Innovation FundLifetime Ventures
Citadel AI is a platform for evaluating and monitoring various AI systems including large language models, image AI, and tabular AI.
AI & Machine LearningEnterprise SoftwareTokyo, JP
Kenny Song(Founder)in
Co-investorsTechstarsUTokyo Innovation Platform Co. Ltd.Coral CapitalMitsubishi UFJ CapitalSuntory Holdings Limited
Golem Network is a decentralized platform that lets users share their unused computing power or rent additional computational resources from others.
Cloud ComputingCrypto & Web3Deep Tech
Piotr Janiuk(CEO)inPaweł Burgchardt(Chief Product Officer)inPrzemysław Rekucki(Chief Technology Officer)
Co-investorsBaseTwoContinue Capital
AI & Machine LearningMarketing TechMedia & EntertainmentSaaS
Co-investorsAspenwoodHummer Winblad Venture Partners (HWVP)DG Daiwa VenturesHummer Winblad Venture PartnersXTech Ventures
JAMM is a members-only community platform where people host activities, meet like-minded people, and discover curated events.
ConsumerSocial
Co-investorsCallapina CapitalDG Daiwa VenturesHummer Winblad Venture PartnersXTech Ventures
Luup operates an electric micro-mobility sharing service providing electric kick scooters and pedal-assist bicycles for short urban trips in Japan.
ConsumerMobility & TransportationSaaSTokyo, JP
Co-investorsDG IncubationGlobal Braini-nest capitalOpen Network LabPKSHA Technology CapitalTBS Innovation Partners+2 more
Refcome operates a referral recruitment service that helps companies hire employees through recommendations from existing staff.
HR TechSaaS
Co-investorsCanal VenturesOriental Land InnovationsBEENEXTItochu Technology Ventures
Develops programmable mRNA therapies that last longer and target cells more precisely for cancer and other diseases.
BiotechBoston, US
Tasuku Kitada(Executive Officer, Director, Promoter)inJacob Becraft(Executive Officer, Director, Promoter)inSamta Kundu(Executive Officer)in
BoardJeb Keiper(Director)inAla Alenazi(Director)inPegah Ebrahimi(Director)in
Co-investorsJIC Venture Growth InvestmentsKinnevikPlayground GlobalAmgen VenturesFPVICONIQ+2 more
Tailor Bio develops targeted cancer therapies for tumors characterized by chromosomal instability, working in the field of precision oncology.
BiotechHealthtech
Co-investorsFirst In VenturesNew Enterprise Associates (NEA)Spiral CapitalY Combinator
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.